Table 6.
Variables | Δ LV MASS | Δ LVEF | Δ MPI | Δ IMT | ||||
---|---|---|---|---|---|---|---|---|
R-value | P-value | R-value | P-value | R-value | P-value | R-value | P-value | |
CRP | 0.251 | 0.058 | 0.018 | 0.892 | 0.211 | 0.112 | 0.308 | 0.021* |
IL6 | 0.272 | 0.039* | 0.147 | 0.270 | 0.226 | 0.088 | 0.272 | 0.039* |
TNFα | 0.147 | 0.271 | 0.165 | 0.216 | 0.087 | 0.517 | 0.147 | 0.271 |
SIRT1 | 0.041 | 0.763 | 0.166 | 0.215 | −0.236 | 0.002* | 0.041 | 0.763 |
Cholesterol | 0.162 | 0.223 | 0.160 | 0.230 | 0.229 | 0.083 | 0.162 | 0.223 |
Creatinine | 0.180 | 0.176 | 0.232 | 0.080 | 0.162 | 0.224 | 0.180 | 0.176 |
Insulin | 0.159 | 0.233 | 0.036 | 0.791 | 0.060 | 0.652 | 0.023 | 0.865 |
HOMA-IR | 0.114 | 0.393 | 0.021 | 0.877 | 0.092 | 0.493 | 0.366 | 0.005* |
Systolicarterial pressure | 0.009 | 0.949 | 0.212 | 0.110 | 0.201 | 0.133 | 0.009 | 0.949 |
Glucose | 0.162 | 0.225 | 0.081 | 0.545 | 0.007 | 0.951 | 0.449 | 0.001* |
In the table is seen linear regression analysis for study variables and study outcomes. For each study outcome the R-value and the p value are reported. The study outcomes are expressed as delta (Δ)-values, that represent changes between follow-up vs. baseline values. The symbol
is indicating a p <0.05. The p <0.05 is indicating a statistically significant p-value. CRP, C reactive protein; HOMA_IR, homeostasis model for the assessment of insulin resistance; IL6, interleukine 6; MPI, myocardium performance index; SIRT1, sirtuin 1; TNFα tumor necrosis factor alpha.